A 42-year-old patient is scheduled for surgery that will likely require a transfusion. Because the patient has a rare blood type, an autologous blood transfusion is planned. Prior to surgery, 1500 mL of blood is collected. The collection tubes contain calcium citrate to prevent coagulation. Which of the following is the mechanism for citrate’s anticoagulative action?
A 42-year-old patient is scheduled for surgery that will likely require a transfusion. Because the patient has a rare blood type, an autologous blood transfusion is planned. Prior to surgery, 1500 mL of blood is collected. The collection tubes contain calcium citrate to prevent coagulation. Which of the following is the mechanism for citrate’s anticoagulative action?
A 42-year-old patient is scheduled for surgery that will likely require a transfusion. Because the patient has a rare blood type, an autologous blood transfusion is planned. Prior to surgery, 1500 mL of blood is collected. The collection tubes contain calcium citrate to prevent coagulation. Which of the following is the mechanism for citrate’s anticoagulative action? A: Activating plasminogen B: Binding factor XII C: Blocking thrombin D: Chelating calcium
A 42-year-old patient is scheduled for surgery that will likely require a transfusion. Because the patient has a rare blood type, an autologous blood transfusion is planned. Prior to surgery, 1500 mL of blood is collected. The collection tubes contain calcium citrate to prevent coagulation. Which of the following is the mechanism for citrate’s anticoagulative action? A: Activating plasminogen B: Binding factor XII C: Blocking thrombin D: Chelating calcium
Inactivation of acetyl CoA carboxylase is favored WHEN: A: Cytosolic citrate levels are high. B: It is in a polymeric form. C: Palmitoyl CoA levels are low. D: The tricarboxylate transporter is inhibited. E: It is dephosphorylated.
Inactivation of acetyl CoA carboxylase is favored WHEN: A: Cytosolic citrate levels are high. B: It is in a polymeric form. C: Palmitoyl CoA levels are low. D: The tricarboxylate transporter is inhibited. E: It is dephosphorylated.
肌酸补剂有哪些种类? A: 一水肌酸(creatine momohydrate) B: 二代肌酸/肌酸乙酯(creatine ethyl ester) C: 磷酸肌酸(creatine phosphate) D: 柠檬肌酸(creatine citrate)
肌酸补剂有哪些种类? A: 一水肌酸(creatine momohydrate) B: 二代肌酸/肌酸乙酯(creatine ethyl ester) C: 磷酸肌酸(creatine phosphate) D: 柠檬肌酸(creatine citrate)
用来测定细菌的生理生化特征的4个实验不包括 A: I:碘(indol)试验 B: M:甲基红(methyl red)试验 C: V:V.(PVoges-Proskauer)试验 D: C:柠檬酸(citrate utilization)实验(枸橼酸盐)
用来测定细菌的生理生化特征的4个实验不包括 A: I:碘(indol)试验 B: M:甲基红(methyl red)试验 C: V:V.(PVoges-Proskauer)试验 D: C:柠檬酸(citrate utilization)实验(枸橼酸盐)
用来测定细菌的生理生化特征的4个实验不包括 A: I:碘(indol)试验 B: M:甲基红(methyl red)试验 C: V:V.(PVoges-Proskauer)试验 D: C:柠檬酸(citrate utilization)实验(枸橼酸盐)
用来测定细菌的生理生化特征的4个实验不包括 A: I:碘(indol)试验 B: M:甲基红(methyl red)试验 C: V:V.(PVoges-Proskauer)试验 D: C:柠檬酸(citrate utilization)实验(枸橼酸盐)
用来测定细菌的生理生化特征的4个实验不包括 A: I:碘(indol)试验 B: M:甲基红(methyl red)试验 C: V:V.(PVoges-Proskauer)试验 D: C:柠檬酸(citrate utilization)实验(枸橼酸盐)
用来测定细菌的生理生化特征的4个实验不包括 A: I:碘(indol)试验 B: M:甲基红(methyl red)试验 C: V:V.(PVoges-Proskauer)试验 D: C:柠檬酸(citrate utilization)实验(枸橼酸盐)